Skip to main content

Table 2 Comparison of treatment characteristics and pregnancy outcomes between the two study groups

From: Impact of preconceptional serum thyroid stimulating hormone values ranging between 2.5 and 4.5 mIU/L on live birth rates following ovulation induction and intrauterine insemination treatment for unexplained infertility

 

TSH 0.27–2.5 mIU/L

n = 543

1110 cycles

TSH 2.51–4.5

n = 183

355 cycles

 

Duration of ovulation induction (days)*

9 (5–12)

9 (5–11)

0.34

Total gonadotrophin dose used (IU)*

525 (262.5–5625)

546 (130–6950)

0.37

Number of follicles > 17 mm on triggerday, n*

1 (0–6)

1 (0–6)

0.65

Clinical pregnancy, n (%cycle)

96 (8.6%)

28 (7.9%)

0.74

Live birth, n (%cycle)

90 (8.1%)

25 (7.1%)

0.38

Miscarriage rate(cycle %)

6 (6.25%)

3 (10.7%)

0.46

  1. TSH, thyroid stimulating hormone; FSH: follicle stimulating hormone; LH: luteinizing hormone
  2. *Values are median (25th–75th percentile)